NCT06368726View on ClinicalTrials.gov

Result of tDCS in ASD Children With Comorbidities Like PANDAS, Rare Genetic Diseases or Autoimmune Disorders

PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

May 1, 2025

Study Completion Date

July 1, 2025

Conditions
AttentionVisual Perceptual WeaknessSocial BehaviorFluency DisorderEEG With Periodic Abnormalities
Interventions
DEVICE

tDCS or Transcranial Direct Current Stimulation

We use weak currents applied over the child's scalp over 30 minutes twice a week during 100 days

DRUG

Risperidone

Risperidone Risperidone according to child's weighs

Trial Locations (1)

L1 0AH

New Remedies, Liverpool

All Listed Sponsors
collaborator

Fundacion para la Salud Materno Infantil

OTHER

lead

Spanish Foundation for Neurometrics Development

OTHER